Milind Deshpande

2009

In 2009, Milind Deshpande earned a total compensation of $540K as President, Research and Development and Chief Scientific Officer at Achillion Pharmaceuticals, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$90,957
Option Awards$141,000
Salary$303,190
Other$4,841
Total$539,988

Deshpande received $303.2K in salary, accounting for 56% of the total pay in 2009.

Deshpande also received $91K in non-equity incentive plan, $141K in option awards and $4.8K in other compensation.

Rankings

In 2009, Milind Deshpande's compensation ranked 6,597th out of 9,885 executives tracked by ExecPay. In other words, Deshpande earned more than 33.3% of executives.

ClassificationRankingPercentile
All
6,597
out of 9,885
33rd
Division
Manufacturing
2,418
out of 3,690
35th
Major group
Chemicals And Allied Products
531
out of 866
39th
Industry group
Drugs
362
out of 638
43rd
Industry
Pharmaceutical Preparations
258
out of 446
42nd
Source: SEC filing on April 16, 2012.

Deshpande's colleagues

We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2009.

2009

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2009

Joseph Truitt

Achillion Pharmaceuticals

Senior Vice President and Chief Commercial Officer

2009

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

2009

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2009

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

News

You may also like